|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,527.90 INR | +1.61% |
|
-1.54% | -9.22% |
| 05-19 | Pfizer Lists New Clinical Trial To Compare Pharmacokinetics Of PF-08049820 In Healthy Adults | CI |
| 05-12 | Pfizer Limited announces Annual dividend, payable on August 27, 2026 | CI |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 267M | 33.65% | 29.78% | 19.65% | - | - | ||
| 65.18B | 31.67% | 41.84% | 106.69% | 22.77% | 1.2x | ||
| 94.19B | 28.46% | 32.23% | 31.68% | 13.82% | 0.84x | ||
| 61.16B | 6.91% | 38.79% | 64,669.09% | 13.22% | 2.44x | ||
| 77.58B | 20.94% | 35.49% | 47.65% | 15.43% | 0.66x | ||
| 65.01B | 28.08% | 41.19% | 45.52% | 17.73% | 1.07x | ||
| 58.74B | 17.41% | 31.46% | 31.99% | 13.12% | 1.2x | ||
| 56.67B | 24.64% | 38.62% | 38.4% | 16.33% | 1.02x | ||
| 48.59B | 33.14% | 41.3% | 60.7% | 20.31% | 0.69x | ||
| 36.75B | 20.98% | 44.09% | 162.88% | 12.98% | 2.13x | ||
| 29.44B | 28.9% | 44.81% | 48.87% | 17.34% | 1.08x | ||
| 62.58B | 12.42% | 35.11% | 21.07% | 8.73% | 1.79x | ||
| 48.19B | 14.64% | 30.37% | 72.08% | 7.72% | 1.83x | ||
| 12B | 32.94% | 43.85% | 27.07% | 16.41% | -1.21x | ||
| 51.22B | 17.91% | 27.85% | 10.5% | 6.02% | 0.81x | ||
| 43.97B | 17.5% | 29.95% | 46.39% | 9.48% | 1.28x | ||
| 8.02B | 34.5% | 47.6% | 22.1% | 25.56% | -0.66x | ||
| 30.6B | 2.36% | 7.48% | 1.5% | 1.19% | 3.6x | ||
| 4.52B | 24.38% | 28.42% | 14.26% | 12.85% | -4.14x | ||
| Average | 44.98B | 22.71% | 35.28% | 3,446.21% | 13.95% | 0.87x | |
| Weighted average by Cap. | 60.48B | 24.12% | 37.66% | 5,870.77% | 16.16% | 1.13x |
- Stock Market
- Stocks
- PFIZER Stock
- Sector Pfizer Limited
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















